{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:18:28Z","timestamp":1758759508533,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.semarthrit.2021.07.013","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T17:22:27Z","timestamp":1627233747000},"page":"1011-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["ANCA status and renal parameters at month 12 post-diagnosis can help predict subsequent relapses in patients with granulomatosis with polyangiitis"],"prefix":"10.1016","volume":"51","author":[{"given":"Lindsay K.","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Carette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.07.013_bib0001","first-page":"1","article-title":"2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0003","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody\u2013associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.04160417","article-title":"The utility of urinalysis in determining the risk of renal relapse in ANCA-associated vasculitis","volume":"13","author":"Rhee","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000500352","article-title":"Prognostic value of microscopic hematuria after induction of remission in antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"49","author":"Vandenbussche","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0006","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0007","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/kei272","article-title":"Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment","volume":"45","author":"Sanders","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2013a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0009","article-title":"There is no benefit in routinely monitoring ANCA titres in patients with granulomatosis with polyangiitis","volume":"33","author":"Verstockt","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3899\/jrheum.120879","article-title":"Urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis","volume":"40","author":"Lieberthal","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0011","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0012","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0013","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3899\/jrheum.150376","article-title":"CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides","volume":"43","author":"McGeoch","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0014","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1097\/01.ASN.0000093256.18266.22","article-title":"High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement","volume":"14","author":"Westman","year":"2003","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/rheumatology\/keq244","article-title":"Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission","volume":"49","author":"Pierrot-Deseilligny Despujol","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0016","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0017","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0018","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2021.02.002","article-title":"Granulomatosis with polyangiitis: study of 795 patients from the French vasculitis study group registry","volume":"51","author":"Iudici","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0019","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2013.11.003","article-title":"Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients","volume":"13","author":"Thai","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0021","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/art.39860","article-title":"Editorial: classifying antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides according to ANCA type or phenotypic diagnosis: salt or pepper?","volume":"68","author":"Pagnoux","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2005.09.022","article-title":"Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review","volume":"47","author":"Birck","year":"2006","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02053","article-title":"Clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3 in ANCA-associated vasculitis","volume":"11","author":"Thompson","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0024","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0026","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.39812","article-title":"Myeloperoxidase\u2013antineutrophil cytoplasmic antibody (ANCA)\u2013positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener's): distinct patient subsets","volume":"68","author":"Miloslavsky","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0027","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0028","article-title":"CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update","author":"Mendel","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0029","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0030","first-page":"77","article-title":"Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement","volume":"7","author":"Iuliana","year":"2014","journal-title":"J Med Life"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0031","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MD.0b013e3181c101cc","article-title":"Persistent hematuria after induction of remission in Wegener granulomatosis: a therapeutic dilemma","volume":"88","author":"Magrey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0032","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3899\/jrheum.111608","article-title":"Persistent or new onset microscopic hematuria in patients with small vessel vasculitis in remission: findings on renal biopsy","volume":"39","author":"Geetha","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0033","first-page":"248","article-title":"End-stage renal disease in ANCA-associated vasculitis","volume":"32","author":"Moiseev","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0034","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0036","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2021.07.013_bib0037","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722100144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722100144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:17Z","timestamp":1758733577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722100144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S004901722100144X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.013","relation":{},"ISSN":["0049-0172"],"issn-type":[{"type":"print","value":"0049-0172"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ANCA status and renal parameters at month 12 post-diagnosis can help predict subsequent relapses in patients with granulomatosis with polyangiitis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}